Changing transplant recipient education and inpatient transplant pharmacy practices: a single-center perspective.

PURPOSE: Pharmacists' contributions to improved inpatient medication practices and educational services for kidney transplant recipients at a community hospital were evaluated. SUMMARY: A retrospective observational analysis was conducted using demographic and case data collected during the year before (2007) and three years after (2011) the inclusion of pharmacists on the hospital's interdisciplinary kidney transplant team. Qualitative variables assessed included changes in prescribing practices, inpatient and outpatient transplant personnel, discharge planning processes, medication reconciliation, educational practices, and transplant program workflow; quantitative variables included average hospital length of stay (LOS), Scientific Registry of Transplant Recipients data, readmission rates, and reimbursement data. A comparison of data on kidney transplant procedures performed at the hospital in 2007 (n = 60) and 2011 (n = 54) indicated that the implementation of specialized transplant pharmacy services was particularly beneficial in the areas of inpatient medication management, medication reconciliation, discharge planning, and patient education. Program outcomes related to the inclusion of pharmacists on the kidney transplant team included a decrease in the mean LOS among transplant recipients (from 7.8 days in 2007 to 3.4 days in 2011, p < 0.001), with no adverse effect on all-cause 30-, 90-, and >90-day readmission rates (all p > 0.09). Annual cost savings attributable to the reduction in LOS were estimated at $279,180. CONCLUSION: The participation of pharmacists on the kidney transplant team enhanced a hospital's medication management, discharge planning, and patient education services for transplant recipients, helping to reduce their average LOS and yielding substantial cost savings.

Morbidity of 200 consecutive cases of hand-assisted laparoscopic living donor nephrectomies: a single-center experience.

Background. Recipients of laparoscopically procured kidneys have been reported to have delayed graft function, a slower creatinine nadir, and potential significant complications. As the technique has evolved laparoscopic donor nephrectomy technique is becoming the gold standard for living donation. Study Design. We retrospectively reviewed the data of the first 200 hand-assisted laparoscopic living donor nephrectomies performed between January 2003 and February 2009. The initial 41 donors and their recipients (Group 1) were compared to the next 159 donors and their recipients (Group 2). The estimated blood loss, serum creatinine at discharge and 6 months, and the incidence of delayed graft function and perioperative complications were analyzed. Results. The median donor serum creatinine at discharge and 6 months was 1.2 mg/dL in each group. None of the laparoscopic procedures required conversion to an open procedure, and none of the donors required perioperative blood transfusion. The median recipient serum creatinine at 6 months after transplant was 1.2 mg/dL for each group. No ischemic ureteral complications related to the laparoscopic technique were seen. Conclusions. HALDN with meticulous surgical technique allows kidney procurement with very low morbidity and no mortality. This improved safety and decreased invasiveness from laparoscopic approach may further decrease morbidity of the procedure and increase organ donation.

Billing for outpatient transplant pharmacy services.

PURPOSE: The economic impact of out-patient pharmacy services in a transplant program was evaluated. METHODS: Full-time kidney transplant pharmacy services were implemented at Providence Sacred Heart Medical Center (PSHMC) in the fall of 2008, with two pharmacists combining hours to provide one full-time-equivalent position. At PSHMC, posttransplantation patients are seen three times per week. The number of patient visits with pharmacists for 2010 was compared with the total number of patient visits. The face-to-face time spent with the patient was translated to a level of billing that was associated with a set reimbursement schedule. For each patient encounter in which a pharmacist was involved, the incremental difference between the nursing and pharmacy levels of billing was examined, as were the levels most often billed by pharmacists. The difference in billing levels between pharmacists and nurses for the same patient encounter was also evaluated. RESULTS: Overall, pharmacist visits accounted for 208 (22%) of the 994 out-patient kidney transplant visits in 2010, with pharmacists billing at a higher level of acuity compared with nursing for the same patient encounter 48% of the time. This translated to an approximate increase of $100 per patient visit. For the one-year study period, pharmacists utilizing facility- fee billing increased out-patient reimbursement by approximately $10,000. CONCLUSION: By utilizing outpatient facility-fee billing for pharmacy services, the transplant program at PSHMC increased reimbursement in the outpatient setting.

Analysis of techniques to secure the renal hilum during laparoscopic donor nephrectomy: review of the FDA database.

OBJECTIVES: To characterize the mechanisms of failure and patient outcomes during complications with the use of endoscopic stapling devices, nonlocking titanium clips, and locking polymer clips during laparoscopic donor nephrectomy. METHODS: The Food and Drug Administration's medical device complication database, Manufacturer and User Facility Device Experience database (MAUDE), was evaluated for pure and hand-assisted laparoscopic donor nephrectomies from 1992 to 2007 with the broadest keywords possible. In an attempt to estimate the failure rates by device type, a "denominator of use" was calculated using Organ Procurement and Transplant Network data multiplied by previously published survey-determined usage rates. RESULTS: In the 92 complications identified, 59 (64%), 21 (23%), and 12 (13%) failures of endoscopic staplers, titanium clips, and locking clips had occurred, respectively. The most common mechanisms of stapler failure were missing/malformed staple lines (51%) and failure to release (25%). The most common titanium clip failures resulted from scissoring or malformation (52%), jamming (19%), and dislodgement (14%). Clip dislodgement was most common with the locking clip, either postoperatively in 7 (58%) or intraoperatively in 3 (25%). Intraoperative conversions were required for 21 (36%), 1 (5%), and 2 (17%) for staplers, titanium clips, and locking clips, respectively. The estimated overall failure rate was 3.0% for staplers, 4.9% for titanium clips, and 1.7% for locking clips. CONCLUSIONS: The anticipation of potential device-specific failures during laparoscopic donor nephrectomy, coupled with knowledge of how to handle failure when it does occur, could improve procedure safety.

Comparison of outcomes with low-dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: a retrospective study.

It is unclear which induction therapy yields the best outcomes in pediatric kidney transplantation. Retrospective data of 88 children receiving a renal allograft between November 1996 and October 2003 were analyzed. Patients received ATGI (n = 12), BI (n = 29), or NAI (n = 47). The mean ATG dose was 5.1 +/- 2.1 mg/kg. At 12 months, graft survival rates were 91.7%, 100%, and 97.9% for ATGI, BI, and NAI groups, respectively. Acute rejection rates at 12 months were 0 (ATGI), 20.6% (BI), and 10.7% (NAI). The mean GFR for ATGI (42.4 +/- 25.9 mL/min) was lower than for BI (78.3 +/- 27.2 mL/min), and NAI (66 +/- 28.3 mL/min) at 12 months (p < 0.05). One ATGI patient developed CMV pneumonia but none developed post-transplant lymphoproliferative disorder. Although there was no renal allograft survival benefit with either ATGI or BI, relative to NAI, the absence of acute rejection and equivalent rates of viral infections in the higher-risk ATGI recipient group suggests that the treatment strategy is promising. A large prospective study is needed to better define the role of ATGI in pediatric kidney transplantation.

Incidence of increased creatine kinase and its effect on kidney function in hand assisted laparoscopic kidney donors and their recipients.

PURPOSE: Rhabdomyolysis is a rare cause of acute renal failure following laparoscopic donor nephrectomy. The incidence of rhabdomyolysis is not well known and to our knowledge the amount of creatine kinase elevation resulting in renal damage is unknown. We evaluated the incidence of increased creatine kinase, risk factors for increased creatine kinase and its effect on renal function in a series of patients undergoing hand assisted laparoscopic donor nephrectomy. MATERIALS AND METHODS: Serum creatine kinase was prospectively measured in 74 consecutive patients who underwent hand assisted laparoscopic donor nephrectomy. These values were measured daily beginning in the recovery room. Demographic and laboratory data, and surgical parameters were analyzed to determine predictors of increased creatine kinase. RESULTS: Eight of 74 patients (10.8%) had a creatine kinase of 2,500 IU/l or greater and 17 (23%) had a creatine kinase of 1,000 IU/l or greater. Factors associated with a creatine kinase of 2,500 IU/l or greater were operative time (320 vs 275 minutes, p = 0.01) and warm ischemia time (192 vs 138 seconds, p <0.01). Operative time remained an independent risk factor on multivariate analysis (p <0.05). There was no difference in preoperative or postoperative donor creatinine between patients with or without increased creatine kinase, although there was an increased percent change in creatinine in the increased creatine kinase group (80% vs 59%, p = 0.04). CONCLUSIONS: Creatine kinase elevation occurs in a small but significant number of patients. Operative time was an independent risk factor for increased creatine kinase. Although creatine kinase had no significant effect on short-term creatinine, there was an increase in the percent change in donor creatinine. Finally, the long-term significance of increased creatine kinase without clinical symptoms is unknown.

Undifferentiated embryonal sarcoma of the liver successfully treated with chemotherapy and liver resection.

Undifferentiated embryonal sarcoma is the third most common malignant tumor of the liver in children, accounting for 13% of hepatic malignancies in this age group. It has been considered an aggressive neoplasm with very poor prognosis until the late 1980s, when long-term survivors were reported after multiagent chemotherapy followed by resection. We, herein, report two pediatric cases of undifferentiated embryonal sarcoma treated successfully with surgical resection after neoadjuvant chemotherapy based on therapy used in childhood soft tissue sarcomas and in childhood hepatic malignancies. The first patient also had a concurrent cerebellar tumor (pilocytic astrocytoma), for which he first underwent craniotomy and resection, delaying the liver tumor resection by 10 weeks. They are alive and tumor free at 48 months (case no. 1) and 18 months (case no. 2) following neoadjuvant chemotherapy and liver resection.

Improved detection of renal vascular anatomy using multidetector CT angiography: Is 100% detection possible?

BACKGROUND AND PURPOSE: Multidetector CT angiography (MDCTA) is being used increasingly to evaluate vascular anatomy prior to donor nephrectomy. To improve the ability of MDCTA to predict donor renal anatomy, a novel protocol including four-phase imaging with three-dimensional reconstruction and maximum intensity projections (MIPs) was incorporated into the standard donor evaluation. The purpose of this study was to determine the results of this protocol. PATIENTS AND METHODS: Seventy consecutive patients who underwent hand-assisted laparoscopic donor nephrectomy between January 2003 and September 2004 were reviewed. All MDCTA studies were examined initially by a radiologist alone, after which, a second preoperative reading was performed by a radiologist and the operating surgeon together. The two reviews were compared with the operative findings. RESULTS: Using this protocol to detect the total number of renal arteries, veins, and ureters, the sensitivity of the initial radiologist was 97%, 100%, and 96%, respectively. These values increased to 100%, 100%, and 99% when the films were reviewed by a radiologist together with the surgeon who would operate on the donor. The sensitivity, specificity, and accuracy in predicting supernumerary arteries, including early (< or =1-cm) arterial branching was 89%, 100%, and 97%, respectively after the single reading but increased to 100%, 100%, and 100% with the combined reading. CONCLUSIONS: An MDCTA study with this protocol provides excellent anatomic detail prior to donor nephrectomy. Its ability to predict renal-arterial and ureteral anatomy is enhanced when the films are reviewed simultaneously by a radiologist and the operating surgeon.

Multidetector computerized tomography angiography to predict lumbar venous anatomy before donor nephrectomy.

PURPOSE: Multidetector computerized tomography angiography has been used to predict renal anatomy before donor nephrectomy. Unrecognized lumbar veins represent a significant risk during laparoscopic surgery but to our knowledge no previous group has attempted to predict lumbar veins with multidetector computerized tomography angiography before laparoscopic donor nephrectomy. We evaluated the ability of multidetector computerized tomography angiography to preoperatively predict the size and location of anomalous left lumbar veins. MATERIALS AND METHODS: A prospective study was performed in patients undergoing left hand assisted laparoscopic donor nephrectomy from January 2003 to September 2004. All patients were imaged using 4-phase computerized tomography, including computerized tomography angiography with 1.25 mm collimation of the arterial and venous phases. Each multidetector computerized tomography angiogram was prospectively reviewed by a radiologist and operating surgeon, and retrospectively reviewed by a second blinded radiologist. RESULTS: A total of 70 patients underwent left hand assisted laparoscopic donor nephrectomy between January 2003 and September 2004. Five patients underwent imaging elsewhere and were excluded from study. Of the remaining 65 patients 54 (83%) had at least 1 anomalous lumbar vein of any size recognized at surgery. Additionally, 33 of these 65 patients (51%) had an anomalous lumbar vein that was 3 mm or greater. These 3 mm or greater vessels carry a significant risk of bleeding and they were used in further calculations. As read by a radiologist and surgeon, the sensitivity and specificity of multidetector computerized tomography angiography compared to surgical identification were 97% and 91%, respectively. Positive and negative predictive values, and accuracy were 91.4%, 97% and 94%, respectively. CONCLUSIONS: Multidetector computerized tomography angiography accurately predicts lumbar venous anatomy before donor nephrectomy with high sensitivity, specificity and accuracy.

Control of the renal artery and vein with the nonabsorbable polymer ligating clip in hand-assisted laparoscopic donor nephrectomy.

BACKGROUND: The large and variable size of the renal vein has prompted most surgeons to select linear stapling devices to secure the vein during laparoscopic donor nephrectomy. Although effective, these stapling devices have a potential for misfire. Use of the nonabsorbable polymer ligating (NPL) clip during laparoscopic donor nephrectomy provides increased graft vessel length compared with the stapling device, and the NPL clip has a locking mechanism which may increase security compared with standard titanium clips. The objective of this study was to evaluate the safety and efficacy of the NPL clip for control of the renal artery and vein during hand-assisted laparoscopic donor nephrectomy (HALDN). METHODS: A retrospective chart review of 50 consecutive HALDN patients was conducted where two parallel NPL clips were used to control both the renal artery and vein. Information collected included demographic data, operative and postoperative data, and complications. RESULTS: Mean donor age was 33.4 years and body mass index was 25.8 kg/m2. Mean operative time was 266.0 min, mean hospital stay was 3.2 days, and mean warm ischemia time was 123.3 seconds. There were no transfusions, open conversions, or complications related to use of the NPL clip. A US 16,300 dollars disposable cost savings was seen during this 1-year period alone. CONCLUSIONS: The NPL clip was 100% safe and effective in controlling the renal artery and vein during HALDN, allowed for additional vessel length, and resulted in a disposable cost savings of US 362 dollars per patient.

Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis.

Nephrogenic fibrosing dermopathy (NFD) is a recently described cutaneous fibrosing disorder associated with renal dysfunction. It appears similar to scleromyxedema but with some notable exceptions, including the lack of involvement of the face and absence of plasma cells on histology, systemic involvement, and paraproteinemia. Patients can present with thickened or edematous skin with indurated papules and plaques involving the extremities and the trunk. We report the first three cases of NFD after liver transplantation successfully treated with plasmapheresis. Two patients underwent liver transplantation for hepatitis C virus-induced cirrhosis and one for hepatitis B virus-induced cirrhosis. All the patients had encephalopathy, refractory ascites, and malnutrition prior to transplantation. Like those patients with NFD, all three of our patients had renal dysfunction and required hemodialysis before and after transplantation. Two were not dependent on dialysis at the time of diagnosis, however. These patients had excellent liver allograft function, but the other patient had allograft failure secondary to recurrent hepatitis C. Immunosuppression therapy consisted of basiliximab, mycophenolate mofetil, calcineurin inhibitor, and prednisone. The patients developed "woody" skin induration of the distal extremities, erythematous papules, and contractures at 1, 2, and 120 months after transplantation. Skin biopsies resembled NFD. No paraproteinemia was evident. One to three 5-day courses of plasmapheresis resulted in moderate to marked clinical improvement. The improvement of the kidney function in two of our patients did not appear to correlate with that of the skin disorder, because the kidney function was improving at the time the diagnosis of NFD was made. In conclusion, we report the first three cases of NFD after liver transplantation. Plasmapheresis was moderately successful in resolving the skin-indurated papules, severe skin induration, and associated joint contractures. Preliminary studies (unpublished data) show that decreasing plasma levels of transforming growth factor-beta1 after plasmapheresis appear to correlate with the amelioration of this clinical condition.